|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-4-8
|
|
pubmed:abstractText |
To clarify the clinical features and prognosis of systemic sclerosis (SSc) based on serum antinuclear antibodies (ANA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
75-83
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8129766-Adolescent,
pubmed-meshheading:8129766-Adult,
pubmed-meshheading:8129766-Aged,
pubmed-meshheading:8129766-Antibodies,
pubmed-meshheading:8129766-Antibodies, Antinuclear,
pubmed-meshheading:8129766-Cause of Death,
pubmed-meshheading:8129766-DNA Topoisomerases, Type I,
pubmed-meshheading:8129766-Female,
pubmed-meshheading:8129766-Humans,
pubmed-meshheading:8129766-Japan,
pubmed-meshheading:8129766-Male,
pubmed-meshheading:8129766-Middle Aged,
pubmed-meshheading:8129766-Retrospective Studies,
pubmed-meshheading:8129766-Ribonucleoprotein, U1 Small Nuclear,
pubmed-meshheading:8129766-Scleroderma, Systemic,
pubmed-meshheading:8129766-Survival Rate
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
|
|
pubmed:affiliation |
Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
